Project
avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for TFDP1
Z-value: 10.27
Motif logo
Transcription factors associated with TFDP1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
TFDP1
|
ENSG00000198176.13 | TFDP1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| TFDP1 | hg38_v1_chr13_+_113584683_113584762 | 0.71 | 3.3e-35 | Click! |
Activity profile of TFDP1 motif
Sorted Z-values of TFDP1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of TFDP1
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 24.3 | 339.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 24.2 | 96.9 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 21.0 | 104.8 | GO:0006344 | optic cup formation involved in camera-type eye development(GO:0003408) maintenance of chromatin silencing(GO:0006344) |
| 18.8 | 56.3 | GO:0075732 | viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
| 17.1 | 85.3 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 15.4 | 138.7 | GO:0006265 | DNA topological change(GO:0006265) |
| 15.0 | 44.9 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 14.9 | 44.8 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 12.9 | 77.2 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 12.5 | 124.8 | GO:0060136 | enucleate erythrocyte differentiation(GO:0043353) embryonic process involved in female pregnancy(GO:0060136) |
| 11.7 | 35.1 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 11.6 | 57.9 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
| 11.4 | 11.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 10.6 | 31.8 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 10.4 | 93.7 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 10.3 | 30.8 | GO:0005999 | xylulose biosynthetic process(GO:0005999) |
| 9.7 | 48.6 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 8.8 | 35.2 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
| 8.7 | 52.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 8.4 | 25.2 | GO:2000176 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 8.1 | 48.8 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 8.1 | 24.2 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 8.0 | 24.0 | GO:1901355 | response to rapamycin(GO:1901355) |
| 8.0 | 80.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 7.9 | 23.8 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
| 7.8 | 31.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 7.7 | 61.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 7.6 | 84.0 | GO:0007144 | female meiosis I(GO:0007144) |
| 7.5 | 22.5 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 7.4 | 29.7 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 7.3 | 29.4 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 7.3 | 7.3 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 7.2 | 28.8 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 7.0 | 21.0 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
| 7.0 | 42.0 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 6.9 | 76.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 6.9 | 27.5 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 6.7 | 6.7 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 6.6 | 19.9 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 6.6 | 6.6 | GO:1903179 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 6.5 | 19.6 | GO:1903004 | flavin adenine dinucleotide metabolic process(GO:0072387) regulation of protein K63-linked deubiquitination(GO:1903004) positive regulation of protein K63-linked deubiquitination(GO:1903006) |
| 6.4 | 19.2 | GO:0021897 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 6.3 | 19.0 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 6.3 | 75.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 6.2 | 36.9 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
| 6.1 | 24.5 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 6.0 | 17.9 | GO:0000967 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 5.9 | 17.8 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
| 5.9 | 17.6 | GO:1904387 | response to human chorionic gonadotropin(GO:0044752) cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 5.8 | 11.7 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
| 5.7 | 23.0 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 5.7 | 74.2 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 5.6 | 28.1 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 5.6 | 50.3 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 5.6 | 72.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 5.5 | 27.7 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 5.4 | 10.9 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
| 5.4 | 21.5 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 5.3 | 10.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 5.3 | 21.0 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 5.2 | 15.6 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 5.2 | 5.2 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 5.2 | 25.8 | GO:0060613 | fat pad development(GO:0060613) |
| 5.1 | 10.2 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 5.1 | 50.8 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 5.1 | 10.2 | GO:0070425 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 5.1 | 40.5 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 5.0 | 9.9 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 4.9 | 14.8 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 4.9 | 44.5 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 4.9 | 79.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 4.8 | 138.3 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 4.5 | 17.9 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 4.4 | 13.1 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
| 4.3 | 13.0 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 4.3 | 52.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
| 4.3 | 8.7 | GO:0035822 | gene conversion(GO:0035822) |
| 4.3 | 12.9 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 4.2 | 4.2 | GO:0061054 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) positive regulation of dermatome development(GO:0061184) |
| 4.2 | 12.7 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 4.2 | 76.1 | GO:0075713 | establishment of integrated proviral latency(GO:0075713) |
| 4.2 | 25.1 | GO:0000012 | single strand break repair(GO:0000012) |
| 4.1 | 12.3 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 4.1 | 12.2 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 4.1 | 12.2 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 4.1 | 68.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 4.0 | 67.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 4.0 | 27.7 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 4.0 | 11.9 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 3.9 | 11.8 | GO:1901254 | modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 3.9 | 15.6 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 3.9 | 7.8 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 3.9 | 19.4 | GO:0015862 | uridine transport(GO:0015862) |
| 3.9 | 7.8 | GO:2000683 | regulation of cellular response to X-ray(GO:2000683) |
| 3.9 | 15.5 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 3.8 | 15.2 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 3.7 | 18.5 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 3.7 | 25.8 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 3.6 | 10.9 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
| 3.6 | 14.5 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 3.6 | 10.9 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 3.6 | 14.4 | GO:0035733 | hepatic stellate cell activation(GO:0035733) |
| 3.6 | 21.4 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 3.6 | 14.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 3.6 | 42.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 3.5 | 28.2 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 3.5 | 28.0 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 3.5 | 10.5 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
| 3.5 | 20.7 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
| 3.4 | 10.3 | GO:2000706 | amniotic stem cell differentiation(GO:0097086) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
| 3.4 | 10.3 | GO:1901874 | negative regulation of post-translational protein modification(GO:1901874) |
| 3.4 | 13.7 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
| 3.4 | 10.3 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 3.3 | 10.0 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 3.3 | 6.6 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 3.3 | 13.3 | GO:0006272 | leading strand elongation(GO:0006272) |
| 3.3 | 19.8 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 3.3 | 131.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 3.3 | 6.6 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 3.3 | 13.1 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 3.3 | 22.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 3.2 | 12.8 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
| 3.2 | 51.2 | GO:0010225 | response to UV-C(GO:0010225) |
| 3.2 | 19.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 3.2 | 19.0 | GO:0048619 | embryonic genitalia morphogenesis(GO:0030538) embryonic hindgut morphogenesis(GO:0048619) |
| 3.2 | 9.5 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 3.1 | 9.3 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 3.1 | 12.2 | GO:0090094 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 3.0 | 9.1 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 3.0 | 33.0 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 3.0 | 47.7 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 3.0 | 68.3 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 2.8 | 8.5 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
| 2.8 | 11.2 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 2.8 | 30.7 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 2.8 | 16.7 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 2.8 | 8.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 2.8 | 16.7 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 2.8 | 13.8 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 2.7 | 2.7 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 2.7 | 10.9 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 2.7 | 21.7 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 2.6 | 13.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 2.6 | 10.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 2.6 | 5.3 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 2.6 | 18.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
| 2.6 | 10.4 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 2.6 | 12.9 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 2.6 | 5.1 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 2.6 | 130.7 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 2.5 | 50.9 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 2.5 | 5.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 2.5 | 37.9 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 2.5 | 55.3 | GO:0061157 | mRNA destabilization(GO:0061157) |
| 2.5 | 2.5 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 2.5 | 7.5 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 2.5 | 2.5 | GO:0060066 | oviduct development(GO:0060066) |
| 2.4 | 7.3 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 2.4 | 2.4 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 2.4 | 7.3 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 2.4 | 16.9 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 2.4 | 31.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 2.4 | 14.4 | GO:0007296 | vitellogenesis(GO:0007296) |
| 2.4 | 16.7 | GO:0021817 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 2.4 | 9.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 2.4 | 14.2 | GO:0090625 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) mRNA cleavage involved in gene silencing(GO:0098795) |
| 2.4 | 11.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 2.4 | 51.7 | GO:0051639 | actin filament network formation(GO:0051639) |
| 2.3 | 4.6 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 2.3 | 9.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 2.3 | 4.6 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
| 2.3 | 20.7 | GO:2000582 | regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 2.3 | 34.3 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 2.3 | 25.1 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 2.3 | 63.6 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
| 2.3 | 9.0 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 2.3 | 31.6 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 2.2 | 8.9 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 2.2 | 6.7 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 2.2 | 6.6 | GO:0030047 | actin modification(GO:0030047) |
| 2.2 | 10.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 2.2 | 6.5 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 2.2 | 13.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 2.2 | 13.0 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
| 2.2 | 34.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 2.2 | 6.5 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 2.1 | 25.5 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 2.1 | 29.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 2.1 | 6.3 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
| 2.1 | 14.8 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 2.1 | 4.2 | GO:0040031 | snRNA modification(GO:0040031) |
| 2.1 | 6.2 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
| 2.0 | 10.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 2.0 | 58.7 | GO:0006465 | signal peptide processing(GO:0006465) |
| 2.0 | 6.1 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 2.0 | 26.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 2.0 | 6.0 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 2.0 | 43.6 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
| 2.0 | 7.9 | GO:0043335 | protein unfolding(GO:0043335) |
| 2.0 | 7.9 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 2.0 | 7.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 2.0 | 19.6 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 1.9 | 5.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 1.9 | 7.7 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 1.9 | 5.8 | GO:0090176 | microtubule cytoskeleton organization involved in establishment of planar polarity(GO:0090176) |
| 1.9 | 9.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 1.9 | 22.7 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 1.9 | 71.7 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 1.9 | 5.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 1.8 | 11.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 1.8 | 5.5 | GO:0032819 | regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) |
| 1.8 | 12.7 | GO:0008215 | spermine metabolic process(GO:0008215) |
| 1.8 | 7.2 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) |
| 1.8 | 45.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 1.8 | 7.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 1.8 | 53.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 1.8 | 5.3 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 1.8 | 151.0 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 1.8 | 15.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 1.8 | 7.0 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 1.7 | 17.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 1.7 | 8.6 | GO:1902741 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 1.7 | 1.7 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 1.7 | 13.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 1.7 | 5.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 1.7 | 6.7 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 1.7 | 38.6 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
| 1.7 | 3.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
| 1.6 | 9.9 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 1.6 | 6.6 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 1.6 | 6.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 1.6 | 278.3 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 1.6 | 32.5 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 1.6 | 1.6 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 1.6 | 3.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 1.6 | 6.4 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 1.6 | 18.9 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 1.6 | 3.1 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 1.6 | 17.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 1.6 | 12.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 1.5 | 21.5 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 1.5 | 27.5 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 1.5 | 4.6 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 1.5 | 31.8 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 1.5 | 4.5 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 1.5 | 9.0 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 1.5 | 7.5 | GO:0007097 | nuclear migration(GO:0007097) |
| 1.5 | 3.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 1.5 | 5.9 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 1.5 | 13.3 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 1.5 | 11.8 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 1.5 | 5.9 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 1.5 | 14.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 1.4 | 11.6 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 1.4 | 10.1 | GO:0030421 | defecation(GO:0030421) |
| 1.4 | 12.9 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
| 1.4 | 4.3 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 1.4 | 17.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 1.4 | 9.9 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 1.4 | 4.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 1.4 | 9.7 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 1.4 | 12.4 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 1.4 | 5.5 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 1.4 | 2.7 | GO:1904732 | regulation of electron carrier activity(GO:1904732) |
| 1.4 | 15.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 1.4 | 12.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 1.4 | 34.0 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 1.4 | 17.6 | GO:0046040 | IMP metabolic process(GO:0046040) |
| 1.3 | 4.0 | GO:1901258 | positive regulation of granulocyte colony-stimulating factor production(GO:0071657) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
| 1.3 | 6.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 1.3 | 3.9 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 1.3 | 19.5 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
| 1.3 | 15.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 1.3 | 3.9 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 1.3 | 15.4 | GO:0042407 | cristae formation(GO:0042407) |
| 1.3 | 7.7 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 1.3 | 5.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 1.3 | 3.8 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 1.3 | 7.6 | GO:0043248 | proteasome assembly(GO:0043248) |
| 1.2 | 6.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 1.2 | 19.9 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 1.2 | 4.9 | GO:1904685 | maintenance of blood-brain barrier(GO:0035633) positive regulation of metalloendopeptidase activity(GO:1904685) |
| 1.2 | 7.3 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 1.2 | 2.4 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 1.2 | 8.5 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 1.2 | 24.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 1.2 | 4.7 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 1.2 | 17.6 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 1.2 | 14.1 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
| 1.2 | 7.0 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
| 1.2 | 8.2 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 1.2 | 34.9 | GO:0007035 | vacuolar acidification(GO:0007035) |
| 1.1 | 5.7 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 1.1 | 9.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 1.1 | 15.7 | GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) |
| 1.1 | 4.5 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 1.1 | 2.2 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
| 1.1 | 18.9 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 1.1 | 13.3 | GO:1903540 | neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
| 1.1 | 4.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 1.1 | 8.9 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 1.1 | 6.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 1.1 | 2.2 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 1.1 | 3.3 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 1.1 | 5.4 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 1.1 | 43.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 1.1 | 8.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 1.1 | 18.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 1.1 | 3.2 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 1.1 | 2.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 1.1 | 2.1 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 1.1 | 15.8 | GO:0051014 | actin filament severing(GO:0051014) |
| 1.0 | 9.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 1.0 | 6.3 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
| 1.0 | 9.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 1.0 | 6.2 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 1.0 | 5.2 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 1.0 | 5.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 1.0 | 33.1 | GO:0002063 | chondrocyte development(GO:0002063) |
| 1.0 | 10.3 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
| 1.0 | 4.1 | GO:0060849 | radial pattern formation(GO:0009956) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 1.0 | 4.1 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 1.0 | 3.1 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 1.0 | 5.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 1.0 | 6.1 | GO:0015853 | adenine transport(GO:0015853) |
| 1.0 | 45.1 | GO:0051225 | spindle assembly(GO:0051225) |
| 1.0 | 9.8 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
| 1.0 | 2.9 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 1.0 | 1.9 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
| 1.0 | 2.9 | GO:0060374 | mast cell differentiation(GO:0060374) |
| 1.0 | 23.0 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 1.0 | 75.2 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.9 | 32.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.9 | 1.9 | GO:0006524 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.9 | 3.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.9 | 3.7 | GO:0003409 | optic vesicle morphogenesis(GO:0003404) optic cup structural organization(GO:0003409) |
| 0.9 | 20.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.9 | 5.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.9 | 6.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.9 | 4.6 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.9 | 11.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.9 | 12.8 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
| 0.9 | 7.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.9 | 16.2 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.9 | 4.5 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.9 | 69.0 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.9 | 6.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.9 | 26.5 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.8 | 8.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 0.8 | 54.3 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.8 | 14.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.8 | 11.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.8 | 11.2 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.8 | 8.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.8 | 2.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.8 | 20.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
| 0.8 | 7.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.8 | 10.7 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.8 | 8.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.8 | 13.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.8 | 2.3 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.8 | 1.5 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.8 | 6.0 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
| 0.7 | 2.2 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.7 | 5.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.7 | 0.7 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.7 | 2.2 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.7 | 5.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.7 | 7.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.7 | 9.1 | GO:0035459 | cargo loading into vesicle(GO:0035459) cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.7 | 2.8 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.7 | 2.7 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.7 | 1.4 | GO:0003186 | tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) |
| 0.7 | 2.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.7 | 24.5 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.7 | 38.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.7 | 18.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.7 | 15.7 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.6 | 10.2 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.6 | 5.1 | GO:0032506 | cytokinetic process(GO:0032506) |
| 0.6 | 3.7 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.6 | 8.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.6 | 6.0 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 0.6 | 15.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.6 | 5.9 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.6 | 1.2 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.6 | 2.3 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.6 | 1.1 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.6 | 6.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.6 | 26.0 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.6 | 0.6 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
| 0.6 | 3.9 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.6 | 8.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.6 | 4.4 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.5 | 1.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.5 | 3.7 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.5 | 4.8 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 0.5 | 7.4 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.5 | 4.8 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.5 | 1.1 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.5 | 3.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.5 | 7.4 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.5 | 23.7 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.5 | 4.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.5 | 2.6 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.5 | 0.5 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.5 | 1.6 | GO:0072007 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 0.5 | 0.5 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.5 | 2.5 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.5 | 4.5 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.5 | 8.5 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.5 | 6.9 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.5 | 7.3 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.5 | 9.7 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.5 | 2.4 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.5 | 1.9 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.5 | 1.4 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.5 | 9.5 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.4 | 3.9 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
| 0.4 | 3.5 | GO:0036093 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.4 | 1.7 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.4 | 4.3 | GO:0030220 | platelet formation(GO:0030220) |
| 0.4 | 8.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.4 | 0.9 | GO:0042418 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.4 | 3.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.4 | 2.5 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.4 | 3.3 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
| 0.4 | 0.4 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
| 0.4 | 5.7 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.4 | 1.6 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.4 | 1.2 | GO:0061010 | negative regulation of transcription by transcription factor localization(GO:0010621) gall bladder development(GO:0061010) hepatic duct development(GO:0061011) |
| 0.4 | 0.8 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.4 | 2.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.4 | 27.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.4 | 0.8 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.4 | 3.9 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.4 | 3.8 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.4 | 2.7 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.4 | 0.4 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.4 | 2.3 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
| 0.4 | 2.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.4 | 0.4 | GO:0032986 | protein-DNA complex disassembly(GO:0032986) |
| 0.4 | 3.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.4 | 1.5 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.4 | 8.5 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.4 | 1.8 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
| 0.4 | 4.1 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.4 | 21.6 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.4 | 2.9 | GO:0060754 | regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.4 | 5.5 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.4 | 2.9 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.4 | 1.4 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.4 | 4.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.3 | 1.7 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.3 | 4.2 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.3 | 5.2 | GO:0051597 | response to methylmercury(GO:0051597) |
| 0.3 | 1.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.3 | 2.8 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.3 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.3 | 3.8 | GO:0001782 | B cell homeostasis(GO:0001782) |
| 0.3 | 2.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.3 | 24.4 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.3 | 8.1 | GO:0042255 | ribosome assembly(GO:0042255) |
| 0.3 | 6.1 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.3 | 1.0 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.3 | 1.0 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.3 | 3.6 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.3 | 6.1 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.3 | 2.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.3 | 3.2 | GO:0045010 | actin nucleation(GO:0045010) |
| 0.3 | 2.2 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.3 | 2.2 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.3 | 0.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.3 | 2.4 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.3 | 10.1 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.3 | 4.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.3 | 2.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.3 | 0.9 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.3 | 0.9 | GO:1900194 | negative regulation of oocyte development(GO:0060283) regulation of oocyte maturation(GO:1900193) negative regulation of oocyte maturation(GO:1900194) |
| 0.3 | 0.9 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.3 | 1.8 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.3 | 9.9 | GO:0035902 | response to immobilization stress(GO:0035902) |
| 0.3 | 2.0 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.3 | 0.9 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.3 | 2.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.3 | 1.1 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.3 | 1.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.3 | 13.4 | GO:0007031 | peroxisome organization(GO:0007031) |
| 0.3 | 5.8 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
| 0.3 | 5.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.3 | 2.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.3 | 1.4 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.3 | 1.6 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.3 | 1.1 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
| 0.3 | 7.6 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.3 | 1.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.3 | 2.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.3 | 1.3 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
| 0.3 | 1.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.3 | 2.3 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.3 | 6.0 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
| 0.3 | 6.7 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.3 | 0.8 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.3 | 5.5 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.3 | 44.3 | GO:0006413 | translational initiation(GO:0006413) |
| 0.2 | 2.7 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.2 | 5.0 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.2 | 8.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.2 | 6.8 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 0.2 | 1.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.2 | 2.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.2 | 0.7 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.2 | 4.7 | GO:0045214 | sarcomere organization(GO:0045214) |
| 0.2 | 0.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 0.2 | 2.0 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.2 | 2.8 | GO:1903543 | positive regulation of exosomal secretion(GO:1903543) |
| 0.2 | 1.7 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.2 | 1.7 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
| 0.2 | 5.6 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.2 | 1.6 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.2 | 12.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
| 0.2 | 2.8 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.2 | 5.6 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
| 0.2 | 1.9 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.2 | 2.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.2 | 0.7 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.2 | 2.9 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
| 0.2 | 1.1 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.2 | 9.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.2 | 0.3 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
| 0.2 | 2.4 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.2 | 0.6 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.2 | 1.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.2 | 0.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.2 | 7.8 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.2 | 1.9 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.2 | 2.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.1 | 9.2 | GO:0019079 | viral genome replication(GO:0019079) |
| 0.1 | 2.0 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 | 0.4 | GO:0035993 | subthalamic nucleus development(GO:0021763) deltoid tuberosity development(GO:0035993) prolactin secreting cell differentiation(GO:0060127) left lung development(GO:0060459) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) endodermal digestive tract morphogenesis(GO:0061031) |
| 0.1 | 2.9 | GO:1902583 | intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
| 0.1 | 0.8 | GO:0015705 | iodide transport(GO:0015705) |
| 0.1 | 0.5 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.1 | 1.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.1 | 1.8 | GO:0001967 | suckling behavior(GO:0001967) |
| 0.1 | 0.6 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
| 0.1 | 0.5 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
| 0.1 | 1.0 | GO:0050942 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
| 0.1 | 0.2 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.1 | 0.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.1 | 5.2 | GO:0045445 | myoblast differentiation(GO:0045445) |
| 0.1 | 7.9 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 0.5 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.1 | 0.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 | 1.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.1 | 2.4 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 6.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.1 | 0.7 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.1 | 8.8 | GO:0070268 | cornification(GO:0070268) |
| 0.1 | 4.9 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.1 | 0.5 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.1 | 1.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 | 0.3 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.1 | 0.5 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 0.7 | GO:0019985 | translesion synthesis(GO:0019985) |
| 0.1 | 1.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 | 0.3 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
| 0.0 | 0.2 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.0 | 0.2 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.0 | 1.4 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
| 0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 | 1.3 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.0 | 18.3 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
| 0.0 | 0.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.0 | 4.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 | 0.3 | GO:0097205 | renal filtration(GO:0097205) |
| 0.0 | 2.0 | GO:0051289 | protein homotetramerization(GO:0051289) |
| 0.0 | 0.3 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) |
| 0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.0 | 0.2 | GO:0051775 | response to redox state(GO:0051775) |
| 0.0 | 0.1 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
| 0.0 | 1.6 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.0 | 0.2 | GO:0033260 | nuclear DNA replication(GO:0033260) |
| 0.0 | 0.1 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.0 | 0.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 0.2 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 26.0 | 286.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 9.9 | 29.6 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 8.9 | 62.0 | GO:0031415 | NatA complex(GO:0031415) |
| 8.2 | 24.7 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 8.2 | 188.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 8.0 | 40.2 | GO:0031523 | Myb complex(GO:0031523) |
| 8.0 | 127.7 | GO:0005642 | annulate lamellae(GO:0005642) |
| 7.5 | 22.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 7.0 | 21.0 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 6.5 | 58.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 6.5 | 38.9 | GO:0097422 | tubular endosome(GO:0097422) |
| 6.5 | 71.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 6.4 | 44.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 6.3 | 12.6 | GO:0035061 | interchromatin granule(GO:0035061) |
| 5.9 | 17.6 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 5.6 | 50.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 5.6 | 258.7 | GO:0090544 | BAF-type complex(GO:0090544) |
| 5.4 | 59.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 5.4 | 37.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 5.3 | 48.1 | GO:0042382 | paraspeckles(GO:0042382) |
| 5.3 | 26.3 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
| 4.9 | 19.6 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 4.8 | 62.6 | GO:0042555 | MCM complex(GO:0042555) |
| 4.8 | 19.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 4.8 | 23.8 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 4.7 | 88.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 4.5 | 22.7 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 4.5 | 81.2 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 4.5 | 17.9 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 4.3 | 21.4 | GO:0016589 | NURF complex(GO:0016589) |
| 4.0 | 59.9 | GO:0097346 | INO80-type complex(GO:0097346) |
| 3.9 | 7.8 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 3.9 | 23.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 3.8 | 19.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 3.8 | 112.9 | GO:0031143 | pseudopodium(GO:0031143) |
| 3.7 | 22.2 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 3.6 | 25.0 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 3.6 | 14.3 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 3.6 | 25.0 | GO:0001939 | female pronucleus(GO:0001939) |
| 3.4 | 17.2 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 3.4 | 17.0 | GO:0005683 | U7 snRNP(GO:0005683) |
| 3.4 | 6.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 3.3 | 73.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 3.3 | 13.4 | GO:0071942 | XPC complex(GO:0071942) |
| 3.3 | 9.9 | GO:0030689 | Noc complex(GO:0030689) |
| 3.2 | 9.5 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 3.1 | 9.4 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 3.1 | 15.6 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 3.1 | 45.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 3.0 | 20.7 | GO:0090543 | Flemming body(GO:0090543) |
| 2.9 | 11.8 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 2.8 | 8.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 2.8 | 11.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 2.6 | 23.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 2.6 | 2.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 2.6 | 15.4 | GO:0061617 | MICOS complex(GO:0061617) |
| 2.5 | 12.7 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 2.5 | 10.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 2.5 | 2.5 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 2.5 | 17.4 | GO:0000125 | PCAF complex(GO:0000125) |
| 2.5 | 2.5 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 2.4 | 22.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 2.4 | 28.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 2.3 | 335.7 | GO:0016605 | PML body(GO:0016605) |
| 2.3 | 21.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 2.3 | 11.7 | GO:0032449 | CBM complex(GO:0032449) |
| 2.3 | 9.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 2.3 | 20.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 2.3 | 13.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 2.3 | 9.0 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 2.2 | 116.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 2.2 | 28.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 2.2 | 33.0 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 2.2 | 32.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 2.2 | 6.5 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 2.2 | 10.8 | GO:0043291 | RAVE complex(GO:0043291) |
| 2.1 | 6.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 2.1 | 10.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 2.1 | 10.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 2.1 | 6.2 | GO:0035517 | PR-DUB complex(GO:0035517) |
| 2.0 | 14.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 2.0 | 2.0 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 2.0 | 6.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 2.0 | 19.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 2.0 | 13.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 1.9 | 35.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 1.9 | 18.7 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 1.9 | 13.0 | GO:0000796 | condensin complex(GO:0000796) |
| 1.8 | 12.8 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 1.8 | 21.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 1.8 | 9.0 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 1.8 | 7.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 1.8 | 22.8 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 1.7 | 18.8 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 1.7 | 5.1 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 1.7 | 339.5 | GO:0000793 | condensed chromosome(GO:0000793) |
| 1.6 | 162.8 | GO:0005811 | lipid particle(GO:0005811) |
| 1.6 | 14.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 1.6 | 26.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 1.6 | 4.9 | GO:0005606 | laminin-1 complex(GO:0005606) |
| 1.6 | 14.6 | GO:0000938 | GARP complex(GO:0000938) |
| 1.6 | 4.7 | GO:1990038 | glial cytoplasmic inclusion(GO:0097409) classical Lewy body(GO:0097414) Lewy neurite(GO:0097462) Lewy body corona(GO:1990038) |
| 1.5 | 4.6 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 1.5 | 189.0 | GO:0016363 | nuclear matrix(GO:0016363) |
| 1.5 | 103.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 1.5 | 45.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 1.5 | 9.1 | GO:0033269 | internode region of axon(GO:0033269) |
| 1.5 | 25.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 1.5 | 23.7 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 1.5 | 23.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 1.4 | 36.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 1.4 | 14.0 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 1.4 | 9.7 | GO:0032021 | NELF complex(GO:0032021) |
| 1.4 | 76.1 | GO:0005876 | spindle microtubule(GO:0005876) |
| 1.4 | 11.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 1.3 | 4.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 1.3 | 14.5 | GO:0005686 | U2 snRNP(GO:0005686) |
| 1.3 | 14.3 | GO:0005915 | zonula adherens(GO:0005915) |
| 1.3 | 12.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 1.3 | 25.7 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 1.3 | 3.8 | GO:0048179 | activin receptor complex(GO:0048179) |
| 1.3 | 8.8 | GO:0010369 | chromocenter(GO:0010369) |
| 1.2 | 6.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 1.2 | 38.5 | GO:0034399 | nuclear periphery(GO:0034399) |
| 1.2 | 1.2 | GO:0071920 | cleavage body(GO:0071920) |
| 1.2 | 10.7 | GO:0005688 | U6 snRNP(GO:0005688) |
| 1.2 | 17.3 | GO:0032059 | bleb(GO:0032059) |
| 1.1 | 6.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 1.1 | 24.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 1.1 | 11.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 1.1 | 5.6 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 1.1 | 2.2 | GO:0000805 | X chromosome(GO:0000805) |
| 1.1 | 3.3 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 1.1 | 26.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 1.1 | 3.2 | GO:0033167 | ARC complex(GO:0033167) |
| 1.1 | 4.3 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 1.1 | 14.0 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 1.1 | 9.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 1.0 | 7.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 1.0 | 20.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 1.0 | 8.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 1.0 | 2.9 | GO:0071817 | MMXD complex(GO:0071817) |
| 1.0 | 13.5 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 1.0 | 13.5 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 1.0 | 29.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.9 | 10.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.9 | 1.9 | GO:0044308 | axonal spine(GO:0044308) |
| 0.9 | 385.5 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.9 | 10.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.9 | 4.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.9 | 1.8 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.9 | 4.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.9 | 20.1 | GO:0046930 | pore complex(GO:0046930) |
| 0.9 | 6.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.8 | 3.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.8 | 13.4 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.8 | 8.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.8 | 4.1 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.8 | 1.6 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.8 | 8.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.8 | 1.6 | GO:0034657 | GID complex(GO:0034657) |
| 0.8 | 60.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.8 | 43.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.7 | 0.7 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.7 | 5.9 | GO:0034709 | methylosome(GO:0034709) |
| 0.7 | 5.2 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.7 | 9.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.7 | 20.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.7 | 14.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.7 | 3.6 | GO:0001652 | granular component(GO:0001652) |
| 0.7 | 7.1 | GO:0051286 | cell tip(GO:0051286) |
| 0.7 | 7.7 | GO:0070449 | elongin complex(GO:0070449) |
| 0.7 | 2.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.7 | 3.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.7 | 0.7 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.7 | 1.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.7 | 3.3 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
| 0.6 | 3.2 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.6 | 28.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.6 | 4.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.6 | 6.9 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.6 | 1.8 | GO:0005592 | collagen type XI trimer(GO:0005592) |
| 0.6 | 6.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.6 | 6.0 | GO:0032039 | integrator complex(GO:0032039) |
| 0.6 | 4.8 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.6 | 96.8 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.6 | 51.7 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.6 | 4.0 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.6 | 4.0 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.6 | 4.5 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.5 | 3.2 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.5 | 6.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.5 | 2.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.5 | 12.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.5 | 13.7 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.5 | 1.5 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.5 | 7.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.5 | 2.5 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.5 | 5.9 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.5 | 4.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.5 | 3.8 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.5 | 8.5 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.5 | 6.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.5 | 5.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.5 | 3.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.5 | 93.2 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.5 | 2.3 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.5 | 0.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.5 | 20.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.5 | 1.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.4 | 3.1 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.4 | 2.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.4 | 9.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.4 | 2.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.4 | 7.7 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
| 0.4 | 2.8 | GO:0070187 | telosome(GO:0070187) |
| 0.4 | 41.5 | GO:0000922 | spindle pole(GO:0000922) |
| 0.4 | 9.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.4 | 1.6 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.4 | 2.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.4 | 10.1 | GO:0002102 | podosome(GO:0002102) |
| 0.4 | 51.8 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.4 | 19.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.4 | 3.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.4 | 15.8 | GO:0042641 | actomyosin(GO:0042641) |
| 0.4 | 6.9 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.4 | 2.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.4 | 13.3 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.3 | 3.1 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.3 | 30.0 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.3 | 25.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.3 | 2.6 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.3 | 2.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.3 | 3.3 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.3 | 4.9 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.3 | 2.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.3 | 18.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.3 | 16.0 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.3 | 7.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.3 | 1.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.3 | 2.2 | GO:0072487 | MSL complex(GO:0072487) |
| 0.3 | 1.9 | GO:0043073 | germ cell nucleus(GO:0043073) |
| 0.2 | 2.7 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.2 | 4.1 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.2 | 4.2 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.2 | 86.0 | GO:0005635 | nuclear envelope(GO:0005635) |
| 0.2 | 3.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.2 | 0.7 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.2 | 1.9 | GO:0036464 | cytoplasmic ribonucleoprotein granule(GO:0036464) |
| 0.2 | 5.8 | GO:0030496 | midbody(GO:0030496) |
| 0.2 | 15.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.2 | 2.4 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.2 | 6.0 | GO:0005605 | basal lamina(GO:0005605) |
| 0.2 | 0.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 0.1 | 13.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.1 | 11.0 | GO:0005776 | autophagosome(GO:0005776) |
| 0.1 | 9.4 | GO:0005819 | spindle(GO:0005819) |
| 0.1 | 1.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 0.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 0.8 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.1 | 0.6 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.1 | 3.9 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.1 | 13.3 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.1 | 3.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 0.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.1 | 7.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.1 | 6.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.1 | 2.2 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.1 | 0.6 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.1 | 1.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.1 | 3.7 | GO:0045095 | keratin filament(GO:0045095) |
| 0.1 | 7.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 1.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.1 | 2.5 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
| 0.1 | 2.1 | GO:0005902 | microvillus(GO:0005902) |
| 0.1 | 2.9 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 8.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 3.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.1 | 7.8 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.1 | 14.1 | GO:0005694 | chromosome(GO:0005694) |
| 0.1 | 2.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 10.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.1 | 0.9 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.1 | 0.6 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.0 | 17.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.0 | 14.0 | GO:0019866 | organelle inner membrane(GO:0019866) |
| 0.0 | 0.1 | GO:0032116 | SMC loading complex(GO:0032116) |
| 0.0 | 62.6 | GO:0070062 | extracellular exosome(GO:0070062) |
| 0.0 | 0.5 | GO:0016592 | mediator complex(GO:0016592) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 24.4 | 97.8 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 19.3 | 57.9 | GO:0043035 | chromatin insulator sequence binding(GO:0043035) |
| 14.5 | 43.4 | GO:0004638 | phosphoribosylaminoimidazole carboxylase activity(GO:0004638) phosphoribosylaminoimidazolesuccinocarboxamide synthase activity(GO:0004639) |
| 13.5 | 67.5 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 13.4 | 133.6 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 12.5 | 37.4 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 10.7 | 53.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 8.5 | 25.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 8.5 | 143.9 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 8.3 | 24.8 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
| 8.2 | 98.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 7.7 | 30.8 | GO:0004802 | transketolase activity(GO:0004802) |
| 7.6 | 22.8 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 7.3 | 7.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 6.9 | 268.8 | GO:0008143 | poly(A) binding(GO:0008143) |
| 6.8 | 61.0 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 6.1 | 61.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 5.9 | 89.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 5.9 | 17.6 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 5.7 | 73.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 5.7 | 39.7 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 5.3 | 15.8 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 5.2 | 20.6 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 5.1 | 25.5 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 5.0 | 70.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 4.8 | 19.3 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 4.5 | 13.6 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 4.5 | 13.5 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 4.5 | 17.9 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
| 4.4 | 48.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 4.4 | 30.5 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 4.3 | 39.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 4.3 | 90.7 | GO:0043495 | protein anchor(GO:0043495) |
| 4.2 | 29.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 4.2 | 172.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 4.1 | 58.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 4.0 | 11.9 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 3.9 | 11.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 3.9 | 85.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 3.9 | 15.5 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 3.8 | 172.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 3.8 | 76.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 3.8 | 15.3 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 3.8 | 15.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 3.8 | 34.1 | GO:0034452 | dynactin binding(GO:0034452) |
| 3.8 | 41.6 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 3.8 | 11.3 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 3.8 | 26.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 3.7 | 104.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 3.7 | 25.8 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 3.6 | 142.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 3.6 | 21.8 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 3.5 | 14.2 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) |
| 3.5 | 21.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 3.5 | 10.5 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 3.4 | 16.9 | GO:0070717 | poly-purine tract binding(GO:0070717) |
| 3.4 | 23.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 3.3 | 23.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 3.3 | 23.2 | GO:0030957 | Tat protein binding(GO:0030957) |
| 3.3 | 16.5 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 3.2 | 9.6 | GO:0051717 | inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity(GO:0051717) |
| 3.2 | 19.0 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 3.2 | 9.5 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 3.1 | 28.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 3.1 | 9.4 | GO:0031753 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
| 3.1 | 104.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 3.1 | 12.3 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 3.0 | 170.4 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 3.0 | 3.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 2.9 | 14.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 2.9 | 37.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 2.9 | 11.6 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
| 2.9 | 54.9 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
| 2.9 | 8.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 2.9 | 8.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 2.9 | 8.6 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 2.8 | 51.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 2.8 | 5.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 2.8 | 11.2 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 2.7 | 13.6 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 2.7 | 32.1 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 2.6 | 10.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 2.6 | 13.0 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 2.6 | 132.7 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 2.5 | 22.7 | GO:0030274 | LIM domain binding(GO:0030274) |
| 2.5 | 22.4 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 2.5 | 9.9 | GO:0004001 | adenosine kinase activity(GO:0004001) |
| 2.4 | 34.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 2.4 | 16.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 2.4 | 16.9 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 2.4 | 135.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 2.3 | 63.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 2.3 | 18.6 | GO:0015288 | porin activity(GO:0015288) |
| 2.3 | 11.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 2.3 | 9.1 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 2.3 | 6.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 2.3 | 6.8 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 2.3 | 15.8 | GO:0000150 | recombinase activity(GO:0000150) |
| 2.3 | 45.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 2.3 | 20.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 2.2 | 15.7 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 2.2 | 11.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 2.2 | 21.9 | GO:0031386 | protein tag(GO:0031386) |
| 2.2 | 6.5 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 2.2 | 6.5 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
| 2.1 | 15.0 | GO:0004459 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
| 2.1 | 23.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 2.1 | 8.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 2.0 | 14.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 2.0 | 22.0 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 2.0 | 15.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 2.0 | 9.8 | GO:0008494 | translation activator activity(GO:0008494) |
| 2.0 | 11.7 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 2.0 | 9.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 1.9 | 11.6 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 1.9 | 43.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 1.9 | 28.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 1.8 | 43.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 1.8 | 34.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 1.8 | 60.6 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 1.8 | 196.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 1.8 | 231.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 1.7 | 6.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 1.7 | 13.6 | GO:0050733 | RS domain binding(GO:0050733) |
| 1.7 | 33.9 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 1.7 | 98.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 1.6 | 1.6 | GO:0043398 | HLH domain binding(GO:0043398) |
| 1.6 | 37.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 1.6 | 67.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 1.6 | 9.5 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 1.6 | 6.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 1.6 | 7.9 | GO:0036033 | mediator complex binding(GO:0036033) |
| 1.6 | 18.9 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 1.6 | 7.8 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 1.6 | 9.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 1.6 | 6.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 1.6 | 24.9 | GO:0070628 | proteasome binding(GO:0070628) |
| 1.5 | 95.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 1.5 | 4.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 1.5 | 4.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 1.5 | 55.4 | GO:0019956 | chemokine binding(GO:0019956) |
| 1.4 | 11.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 1.4 | 8.6 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 1.4 | 7.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 1.4 | 38.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 1.4 | 59.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 1.3 | 13.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 1.3 | 10.7 | GO:0031491 | nucleosome binding(GO:0031491) |
| 1.3 | 27.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 1.3 | 2.6 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 1.3 | 3.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 1.3 | 12.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 1.3 | 3.8 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 1.3 | 8.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 1.2 | 34.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 1.2 | 11.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 1.2 | 7.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 1.2 | 6.1 | GO:0034648 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 1.2 | 4.8 | GO:1990254 | keratin filament binding(GO:1990254) |
| 1.2 | 9.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 1.2 | 3.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 1.1 | 28.7 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 1.1 | 26.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 1.1 | 19.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 1.1 | 5.7 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 1.1 | 3.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 1.1 | 1.1 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 1.1 | 9.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 1.1 | 14.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 1.1 | 3.2 | GO:0016296 | [acyl-carrier-protein] S-malonyltransferase activity(GO:0004314) 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
| 1.1 | 8.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 1.1 | 19.2 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 1.1 | 36.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 1.1 | 8.5 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 1.1 | 10.6 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
| 1.0 | 7.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 1.0 | 5.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 1.0 | 10.2 | GO:0038132 | neuregulin binding(GO:0038132) |
| 1.0 | 3.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 1.0 | 7.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 1.0 | 6.0 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 1.0 | 5.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 1.0 | 7.9 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 1.0 | 49.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 1.0 | 2.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 1.0 | 19.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 1.0 | 20.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 1.0 | 20.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 1.0 | 20.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 1.0 | 2.9 | GO:0055100 | adiponectin binding(GO:0055100) |
| 1.0 | 16.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 1.0 | 18.1 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.9 | 70.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.9 | 3.8 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.9 | 9.4 | GO:0034594 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
| 0.9 | 7.5 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.9 | 11.2 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.9 | 2.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 0.9 | 111.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.9 | 23.7 | GO:0046961 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.9 | 14.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.9 | 53.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.9 | 12.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.9 | 24.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.9 | 4.4 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.9 | 4.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.9 | 192.4 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.8 | 5.9 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.8 | 3.3 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.8 | 4.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.8 | 106.1 | GO:0042393 | histone binding(GO:0042393) |
| 0.8 | 4.8 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.8 | 16.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.8 | 10.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.8 | 11.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.8 | 3.8 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
| 0.7 | 0.7 | GO:0003909 | DNA ligase activity(GO:0003909) |
| 0.7 | 7.4 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.7 | 17.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.7 | 2.1 | GO:0048030 | disaccharide binding(GO:0048030) |
| 0.7 | 3.5 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.7 | 9.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 0.7 | 18.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.7 | 11.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.7 | 15.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.7 | 2.7 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.7 | 17.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.7 | 7.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.7 | 10.4 | GO:0005521 | lamin binding(GO:0005521) |
| 0.6 | 3.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.6 | 4.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.6 | 5.7 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.6 | 16.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.6 | 12.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.6 | 2.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.6 | 19.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.6 | 21.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.6 | 44.2 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.6 | 1.7 | GO:0015556 | malate transmembrane transporter activity(GO:0015140) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
| 0.6 | 11.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.6 | 60.7 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.6 | 10.4 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.6 | 11.0 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.6 | 14.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.6 | 8.0 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.6 | 6.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.6 | 5.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.6 | 4.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.6 | 7.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.6 | 3.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.5 | 3.8 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.5 | 4.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.5 | 3.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.5 | 25.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.5 | 4.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.5 | 2.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.5 | 2.1 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
| 0.5 | 4.7 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.5 | 6.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.5 | 3.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.5 | 4.1 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.5 | 7.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.5 | 9.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.5 | 2.0 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.5 | 6.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.5 | 2.5 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.5 | 11.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.5 | 1.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.5 | 4.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.5 | 32.2 | GO:0031072 | heat shock protein binding(GO:0031072) |
| 0.4 | 4.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.4 | 1.8 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.4 | 8.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.4 | 3.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.4 | 4.2 | GO:0016896 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
| 0.4 | 3.4 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 0.4 | 2.5 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.4 | 4.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.4 | 34.9 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.4 | 7.1 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.4 | 13.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.3 | 25.9 | GO:0019003 | GDP binding(GO:0019003) |
| 0.3 | 9.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.3 | 3.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.3 | 22.4 | GO:0004386 | helicase activity(GO:0004386) |
| 0.3 | 16.0 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.3 | 1.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
| 0.3 | 6.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.3 | 15.9 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.3 | 2.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.3 | 0.9 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.3 | 1.2 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.3 | 1.2 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.3 | 4.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.3 | 2.3 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.3 | 1.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.3 | 1.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.3 | 1.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.3 | 4.6 | GO:0015926 | glucosidase activity(GO:0015926) |
| 0.3 | 4.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
| 0.3 | 12.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.2 | 5.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
| 0.2 | 3.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.2 | 1.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.2 | 1.0 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.2 | 5.3 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.2 | 4.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.2 | 4.0 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.2 | 28.7 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.2 | 0.9 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.2 | 4.2 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.2 | 1.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.2 | 0.9 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 0.2 | 0.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
| 0.2 | 0.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.2 | 4.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.2 | 3.4 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.2 | 0.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.2 | 0.8 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.2 | 15.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.2 | 4.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.2 | 0.5 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
| 0.2 | 1.1 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.2 | 2.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.2 | 2.0 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.1 | 125.7 | GO:0003723 | RNA binding(GO:0003723) |
| 0.1 | 0.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.1 | 8.6 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.1 | 7.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.1 | 23.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 2.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 1.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.1 | 0.6 | GO:0045182 | translation regulator activity(GO:0045182) |
| 0.1 | 1.8 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.1 | 1.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.1 | 0.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.1 | 1.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.1 | 0.5 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.1 | 1.0 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.1 | 4.8 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.1 | 0.5 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.1 | 1.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.1 | 0.3 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.1 | 1.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.1 | 0.8 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.1 | 0.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.1 | 0.7 | GO:0008198 | ferrous iron binding(GO:0008198) |
| 0.1 | 1.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.1 | 0.2 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.0 | 0.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.0 | 1.9 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.0 | 0.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.0 | 0.1 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
| 0.0 | 0.4 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.0 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.0 | 0.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.0 | 0.2 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.7 | 79.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 4.2 | 198.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 4.1 | 144.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 3.1 | 123.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 2.8 | 293.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 2.8 | 57.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 2.7 | 46.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 2.6 | 265.9 | PID E2F PATHWAY | E2F transcription factor network |
| 2.2 | 78.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 2.2 | 69.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 2.2 | 26.1 | PID BARD1 PATHWAY | BARD1 signaling events |
| 2.1 | 67.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 2.1 | 107.0 | PID AURORA B PATHWAY | Aurora B signaling |
| 1.9 | 19.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 1.9 | 98.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 1.8 | 141.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 1.7 | 38.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 1.6 | 51.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 1.5 | 63.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 1.5 | 110.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 1.3 | 46.0 | PID RHOA PATHWAY | RhoA signaling pathway |
| 1.2 | 114.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 1.2 | 73.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 1.1 | 28.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 1.1 | 59.7 | PID P53 REGULATION PATHWAY | p53 pathway |
| 1.0 | 93.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 1.0 | 30.1 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.9 | 24.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.9 | 14.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.9 | 53.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.9 | 14.9 | PID ATR PATHWAY | ATR signaling pathway |
| 0.9 | 2.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.8 | 39.6 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.8 | 31.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.7 | 51.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.7 | 25.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.6 | 14.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.6 | 27.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.6 | 9.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.5 | 18.9 | PID BMP PATHWAY | BMP receptor signaling |
| 0.5 | 18.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.5 | 13.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.5 | 7.6 | PID ATM PATHWAY | ATM pathway |
| 0.5 | 12.0 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.5 | 12.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.5 | 44.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.4 | 2.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.4 | 7.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.4 | 1.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.3 | 17.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.3 | 4.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.3 | 13.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.2 | 15.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.2 | 3.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.2 | 0.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.2 | 6.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.2 | 4.7 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.2 | 0.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.2 | 4.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.2 | 5.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.2 | 1.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.2 | 14.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.2 | 5.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.1 | 4.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.1 | 0.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 1.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.0 | 1.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.0 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 0.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.0 | 0.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 14.7 | 220.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 8.6 | 94.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 7.2 | 7.2 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 5.5 | 127.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 5.5 | 158.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 4.6 | 146.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 4.5 | 67.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 4.4 | 53.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 4.1 | 4.1 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
| 4.0 | 60.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 3.8 | 76.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 3.6 | 54.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 3.3 | 120.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 3.1 | 112.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 3.0 | 30.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 2.9 | 96.9 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 2.7 | 106.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 2.6 | 57.0 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 2.6 | 62.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 2.6 | 48.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 2.5 | 22.7 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 2.5 | 132.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 2.4 | 14.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 2.4 | 31.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 2.4 | 390.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 2.3 | 23.3 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
| 2.3 | 34.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 2.0 | 60.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 1.9 | 28.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 1.9 | 68.8 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 1.8 | 14.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 1.7 | 84.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 1.7 | 12.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 1.7 | 5.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 1.7 | 16.5 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 1.6 | 27.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 1.5 | 66.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 1.5 | 39.3 | REACTOME KINESINS | Genes involved in Kinesins |
| 1.5 | 19.0 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
| 1.5 | 100.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
| 1.4 | 42.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 1.3 | 16.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 1.2 | 52.0 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 1.2 | 36.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 1.2 | 25.7 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 1.2 | 13.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 1.1 | 19.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 1.1 | 33.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 1.1 | 19.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 1.0 | 3.1 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
| 1.0 | 17.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 1.0 | 12.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 1.0 | 46.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 1.0 | 31.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.9 | 29.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.9 | 21.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.9 | 3.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.9 | 21.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.9 | 43.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.9 | 34.7 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.9 | 13.6 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.8 | 42.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.8 | 25.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.8 | 6.5 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
| 0.8 | 22.3 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.8 | 115.1 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
| 0.8 | 6.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.7 | 30.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.7 | 19.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.7 | 28.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.7 | 35.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.7 | 52.4 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 0.7 | 6.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.7 | 54.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.7 | 14.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.6 | 5.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.6 | 11.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.6 | 8.2 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
| 0.6 | 17.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
| 0.6 | 45.7 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.6 | 14.6 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.6 | 97.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.6 | 6.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.6 | 18.0 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.6 | 10.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.6 | 1.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.5 | 26.2 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.5 | 6.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.5 | 5.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.5 | 7.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.5 | 11.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.4 | 22.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.4 | 2.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.4 | 41.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.4 | 15.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.4 | 17.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.4 | 7.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.4 | 2.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.4 | 2.8 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.3 | 15.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.3 | 2.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.3 | 19.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.3 | 8.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.3 | 5.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.3 | 27.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.2 | 19.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.2 | 4.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.2 | 3.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.2 | 2.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.2 | 1.1 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| 0.2 | 1.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.2 | 1.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.2 | 7.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.2 | 5.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.2 | 0.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.2 | 9.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.2 | 12.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.2 | 9.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.1 | 14.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.1 | 1.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.1 | 1.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.1 | 5.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.1 | 1.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.1 | 4.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.1 | 1.6 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
| 0.1 | 1.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.1 | 2.7 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.1 | 1.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 1.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.1 | 3.6 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
| 0.0 | 0.7 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.0 | 1.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.0 | 0.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.0 | 0.7 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
| 0.0 | 0.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.0 | 0.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |